Order Article Reprints

Koya T, Yoshida K, Togi M, Niida Y, Togi S, Ura H, Mizuta S, Kato T Jr., Yamada S, Shibata T, et al. Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells. Cancers. 2023; 15(14):3627. https://doi.org/10.3390/cancers15143627

Koya, Terutsugu, Kenichi Yoshida, Misa Togi, Yo Niida, Sumihito Togi, Hiroki Ura, Shuichi Mizuta, Tomohisa Kato, Jr., Sohsuke Yamada, Takeo Shibata, and et al. 2023. "Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells" Cancers 15, no. 14: 3627. https://doi.org/10.3390/cancers15143627

Koya, T., Yoshida, K., Togi, M., Niida, Y., Togi, S., Ura, H., Mizuta, S., Kato, T., Jr., Yamada, S., Shibata, T., Liu, Y. -C., Yuan, S. -S., Wu, D. -C., Kobayashi, H., Utsugisawa, T., Kanno, H., & Shimodaira, S. (2023). Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells. Cancers, 15(14), 3627. https://doi.org/10.3390/cancers15143627